{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:38:11Z","timestamp":1792172291047,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000139","name":"U.S. Environmental Protection Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1145634"],"award-info":[{"award-number":["APP1145634"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1156072"],"award-info":[{"award-number":["GNT1156072"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1154651"],"award-info":[{"award-number":["GNT1154651"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1125000"],"award-info":[{"award-number":["GNT1125000"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1104460"],"award-info":[{"award-number":["GNT1104460"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005298","name":"American College of Neuropsychopharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.pnpbp.2022.110550","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T12:48:53Z","timestamp":1647348533000},"page":"110550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"117","author":[{"given":"Jerome","family":"Sarris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Bousman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan","family":"Cribb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Blair-West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlasios","family":"Brakoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Camfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Ee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel","family":"Chamoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najwa-Joelle","family":"Metri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Karamacoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Rossell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee H.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pnpbp.2022.110550_bb0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1037\/a0018260","article-title":"Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the dimensional obsessive-compulsive scale","volume":"22","author":"Abramowitz","year":"2010","journal-title":"Psychol. Assess."},{"issue":"6","key":"10.1016\/j.pnpbp.2022.110550_bb0010","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0b013e318272677d","article-title":"N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, Placebo-Controlled Trial","volume":"32","author":"Afshar","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2022.110550_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) Arlington","first-page":"1000","author":"American Psychiatric Association","year":"2013"},{"issue":"1","key":"10.1016\/j.pnpbp.2022.110550_bb0020","first-page":"74","article-title":"The lme4 package","volume":"2","author":"Bates","year":"2007","journal-title":"R package version"},{"issue":"6","key":"10.1016\/j.pnpbp.2022.110550_bb0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"issue":"3","key":"10.1016\/j.pnpbp.2022.110550_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.pnpbp.2022.110550_bb0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4088\/JCP.13m08454","article-title":"The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial","volume":"75","author":"Berk","year":"2014","journal-title":"J. Clin. Psychiatr."},{"issue":"8","key":"10.1016\/j.pnpbp.2022.110550_bb0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110550_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.comppsych.2015.10.005","article-title":"Validation of the NetSCID: an automated web-based adaptive version of the SCID","volume":"66","author":"Brodey","year":"2016","journal-title":"Compr. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2022.110550_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2515245918823199","article-title":"Ordinal regression models in psychology: a tutorial","volume":"2","author":"B\u00fcrkner","year":"2019","journal-title":"Adv. Methods Pract. Psychol. Sci."},{"key":"10.1016\/j.pnpbp.2022.110550_bb0055","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in R","author":"Buuren","year":"2010","journal-title":"J. Stat. Softw."},{"issue":"7","key":"10.1016\/j.pnpbp.2022.110550_bb0060","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.4088\/JCP.16m11101","article-title":"Randomized, double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive disorder","volume":"78","author":"Costa","year":"2017","journal-title":"J. Clin. Psychiatr."},{"issue":"4","key":"10.1016\/j.pnpbp.2022.110550_bb0065","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.15r09984","article-title":"N-acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis","volume":"77","author":"Fernandes","year":"2016","journal-title":"J. Clin. Psychiatr."},{"issue":"4","key":"10.1016\/j.pnpbp.2022.110550_bb0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/YIC.0000000000000314","article-title":"Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders","volume":"35","author":"Fineberg","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2022.110550_bb0075","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.brat.2004.11.007","article-title":"How effective are cognitive and behavioral treatments for obsessive\u2013compulsive disorder? A clinical significance analysis","volume":"43","author":"Fisher","year":"2005","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.pnpbp.2022.110550_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocrd.2020.100529","article-title":"Efficacy and safety of N-acetylcysteine as add-on therapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"25","author":"Gadallah","year":"2020","journal-title":"J. Obsess.-Compulsive and Related Disorders"},{"issue":"2","key":"10.1016\/j.pnpbp.2022.110550_bb0085","first-page":"134","article-title":"Efficacy of N-acetylcysteine augmentation on obsessive compulsive disorder: a multicenter randomized double blind placebo controlled clinical trial","volume":"12","author":"Ghanizadeh","year":"2017","journal-title":"Iran. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2022.110550_bb0090","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110550_bb0095","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"2","key":"10.1016\/j.pnpbp.2022.110550_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"issue":"1","key":"10.1016\/j.pnpbp.2022.110550_bb0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1037\/1082-989X.2.1.64","article-title":"Application of random-effects pattern-mixture models for missing data in longitudinal studies","volume":"2","author":"Hedeker","year":"1997","journal-title":"Psychol. Methods"},{"issue":"13","key":"10.1016\/j.pnpbp.2022.110550_bb0110","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.2200","article-title":"Obsessive-compulsive disorder: advances in diagnosis and treatment","volume":"317","author":"Hirschtritt","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2022.110550_bb0115","series-title":"Clinical Significance: A Statistical Approach to Defining Meaningful Change in Psychotherapy Research","author":"Jacobson","year":"1992"},{"issue":"1","key":"10.1016\/j.pnpbp.2022.110550_bb0120","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatr."},{"issue":"2","key":"10.1016\/j.pnpbp.2022.110550_bb0125","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol. Bull."},{"issue":"5","key":"10.1016\/j.pnpbp.2022.110550_bb0130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/acps.13026","article-title":"Oxidative and nitrosative stress markers in obsessive\u2013compulsive disorder: a systematic review and meta-analysis","volume":"139","author":"Maia","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.pnpbp.2022.110550_bb0135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2174\/1570159X15666170320104237","article-title":"Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder","volume":"15","author":"Marinova","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2022.110550_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/wps.20299","article-title":"Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder","volume":"15","author":"Mataix-Cols","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110550_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eurpsy.2018.05.006","volume":"53","author":"Mohebbi","year":"2018","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.pnpbp.2022.110550_bb0150","doi-asserted-by":"crossref","first-page":"2469486","DOI":"10.1155\/2018\/2469486","article-title":"N-acetylcysteine for the treatment of psychiatric disorders: a review of current evidence","volume":"2018","author":"Ooi","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.pnpbp.2022.110550_bb0155","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.pnpbp.2022.110550_bb0160","doi-asserted-by":"crossref","unstructured":"Paydary, K., Akamaloo, A., Ahmadipour, A., Pishgar, F., Emamzadehfard, S., & Akhondzadeh, S. (2016). N-acetylcysteine augmentation therapy for moderate-to-severe obsessive\u2013compulsive disorder: randomized, double-blind, placebo-controlled trial. J. Clin. Pharm. Ther., 41(2), 214\u2013219. doi:https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/jcpt.12370.","DOI":"10.1111\/jcpt.12370"},{"issue":"3","key":"10.1016\/j.pnpbp.2022.110550_bb0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.psc.2014.05.006","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2014","journal-title":"Psychiatr. Clin. North Am."},{"issue":"6","key":"10.1016\/j.pnpbp.2022.110550_bb0170","first-page":"10","article-title":"SNRIs pharmacological alternatives for the treatment of obsessive compulsive disorder?","volume":"8","author":"Sansone","year":"2011","journal-title":"Innov. Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.pnpbp.2022.110550_bb0175","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s40263-015-0272-9","article-title":"N-acetyl cysteine (NAC) in the treatment of obsessive-compulsive disorder: a 16-week, double-blind, randomised, Placebo-Controlled Study","volume":"29","author":"Sarris","year":"2015","journal-title":"CNS Drugs"},{"issue":"Suppl. 3","key":"10.1016\/j.pnpbp.2022.110550_bb0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2022.110550_bb0185","series-title":"Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence","author":"Singer","year":"2003"},{"issue":"8","key":"10.1016\/j.pnpbp.2022.110550_bb0190","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110550_bb0195","series-title":"R: A Language and Environment for Statistical Computing: Vienna, Austria","author":"Team","year":"2013"},{"issue":"3","key":"10.1016\/j.pnpbp.2022.110550_bb0200","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group","volume":"28","author":"WHO","year":"1998","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2022.110550_bb0205","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"issue":"8","key":"10.1016\/j.pnpbp.2022.110550_bb0210","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton depression rating scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2022.110550_bb0215","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0004867419893439","article-title":"Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia","volume":"54","author":"Yolland","year":"2020","journal-title":"Austr. & New Zealand J. Psychiatr."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584622000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584622000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:53:51Z","timestamp":1778741631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584622000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":43,"alternative-id":["S0278584622000422"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110550","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110550"}}